B. Agerberth

发表

Antimicrobial Polypeptides of Human Vernix Caseosa and Amniotic Fluid: Implications for Newborn Innate Defense

H. Lagercrantz, H. Jörnvall, Hiroyuki Yoshio, 2003, Pediatric Research.

Isolation and identification of antimicrobial components from the epidermal mucus of Atlantic cod (Gadus morhua)

H. Jörnvall, G. H. Gudmundsson, B. Agerberth, 2005, The FEBS journal.

Vernix caseosa as a multi-component defence system based on polypeptides, lipids and their interactions

H. Jörnvall, W. Griffiths, J. Lengqvist, 2005, Cellular and Molecular Life Sciences CMLS.

Apolipoprotein A-I Binds and Inhibits the Human Antibacterial/Cytotoxic Peptide LL-37*

J. Johansson, Y. Wang, B. Agerberth, 1998, The Journal of Biological Chemistry.

Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic.

D. Sack, J. Andersson, R. Raqib, 2006, Proceedings of the National Academy of Sciences of the United States of America.

The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection

T. Hökfelt, L. Kovács, R. Gallo, 2006, Nature Medicine.

The antimicrobial peptide LL-37 inhibits HIV-1 replication.

J. Söderlund, B. Agerberth, P. Bergman, 2007, Current HIV research.

Entinostat up-regulates the CAMP gene encoding LL-37 via activation of STAT3 and HIF-1α transcription factors

Elias S. J. Arnér, R. Strömberg, M. Cebula, 2016, Scientific Reports.

Helping the Host: Induction of Antimicrobial Peptides as a Novel Therapeutic Strategy Against Infections

G. H. Gudmundsson, B. Agerberth, P. Bergman, 2013 .

Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis

R. Raqib, R. Rekha, G. H. Gudmundsson, 2013, BMC Pulmonary Medicine.

Specificity in Killing Pathogens Is Mediated by Distinct Repertoires of Human Neutrophil Peptides

B. Agerberth, P. Bergman, A. Cederlund, 2010, Journal of Innate Immunity.

Battle and balance at mucosal surfaces--the story of Shigella and antimicrobial peptides.

J. Andersson, R. Raqib, G. H. Gudmundsson, 2010, Biochemical and biophysical research communications.

Enhanced expression of the antimicrobial peptide LL‐37 in lesional skin of adults with atopic eczema

A. Scheynius, G. Lilja, B. Agerberth, 2009, The British journal of dermatology.

Antimicrobial Components of the Neonatal Gut Affected Upon Colonization

H. Jörnvall, G. H. Gudmundsson, G. Marchini, 2007, Pediatric Research.

Induction of the Antimicrobial Peptide CRAMP in the Blood-Brain Barrier and Meninges after Meningococcal Infection

T. Hökfelt, R. Gallo, G. H. Gudmundsson, 2006, Infection and Immunity.

, Allison Meninges after Meningococcal Infection CRAMP in the Blood-Brain Barrier and Induction of the Antimicrobial Peptide

T. Hökfelt, R. Gallo, G. H. Gudmundsson, 2006 .

The antimicrobial peptide rCRAMP is present in the central nervous system of the rat

Ernest Arenas, T. Hökfelt, E. Arenas, 2005, Journal of neurochemistry.

Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL‐37

G. H. Gudmundsson, B. Agerberth, P. Bergman, 2005, Cellular microbiology.

First line of defense in early human life.

H. Lagercrantz, Hiroyuki Yoshio, G. H. Gudmundsson, 2004, Seminars in perinatology.

FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis.

J. Odeberg, H. G. Boman, G. H. Gudmundsson, 1995, Proceedings of the National Academy of Sciences of the United States of America.

The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes.

J. Odeberg, T. Bergman, R. Salcedo, 1996, European journal of biochemistry.

Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine

H. G. Boman, A. Boman, B. Agerberth, 1993, Infection and immunity.

Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus.

V. Nizet, T. Ohtake, R. Gallo, 2001, The Journal of investigative dermatology.

Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways

H. Lührs, G. H. Gudmundsson, B. Agerberth, 2003, Gut.

Antibacterial peptides in stimulated human granulocytes: characterization of ubiquitinated histone H1A.

J. Johansson, H. Jörnvall, W. Griffiths, 2002, European journal of biochemistry.

Impaired Release of Antimicrobial Peptides into Nasal Fluid of Hyper-IgE and CVID Patients

S. Normark, L. Lindbom, J. Andersson, 2011, PloS one.

Lactose in Human Breast Milk an Inducer of Innate Immunity with Implications for a Role in Intestinal Homeostasis

H. Lagercrantz, H. Jörnvall, R. Strömberg, 2013, PloS one.

Preparation the Presence of a Lung Surfactant Prophenin ( Residues 62 to 79 ) and LL-37 in Antibacterial Activities of the Cathelicidins

J. Johansson, B. Agerberth, E. Herting, 2004 .

Antibacterial Activities of the Cathelicidins Prophenin (Residues 62 to 79) and LL-37 in the Presence of a Lung Surfactant Preparation

J. Johansson, B. Agerberth, E. Herting, 2004, Antimicrobial Agents and Chemotherapy.

Cod cathelicidin: isolation of the mature peptide, cleavage site characterisation and developmental expression.

H. Jörnvall, V. H. Maier, G. H. Gudmundsson, 2011, Developmental and comparative immunology.

Klebsiella pneumoniae Expressing VIM-1 Metallo-β-Lactamase Is Resensitized to Cefotaxime via Thiol-Mediated Zinc Chelation

C. Giske, Yang Wang, Zhihai Liu, 2019, Infection and Immunity.

Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes

Y. Simoni, A. Lehuen, J. Diana, 2012, Nature Medicine.

Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns

T. Hökfelt, M. Partinen, C. Adori, 2014, Proceedings of the National Academy of Sciences.

Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial

A. Cravioto, J. Andersson, R. Raqib, 2012, BMC Infectious Diseases.

No Evidence of Pathogenic Involvement of Cathelicidins in Patient Cohorts and Mouse Models of Lupus and Arthritis

A. Barron, K. Amann, G. Schett, 2014, PloS one.

Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes

R. Raqib, S. Brighenti, B. Agerberth, 2020, BMC Infectious Diseases.

Leukotriene B4/antimicrobial peptide LL‐37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1

J. Haeggström, C. Godson, P. Guiry, 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Uropathogenic Escherichia coli Modulates Immune Responses and Its Curli Fimbriae Interact with the Antimicrobial Peptide LL-37

K. Hedlund, J. Johansson, M. Chapman, 2010, PLoS pathogens.

Lactose Induces Phenotypic and Functional Changes of Neutrophils and Macrophages to Alleviate Acute Pancreatitis in Mice

Li-Long Pan, Wenying Niu, M. Bhatia, 2018, Front. Immunol..

Protein biomarkers in vernix with potential to predict the development of atopic eczema in early childhood

R. Zubarev, A. Scheynius, D. Rutishauser, 2013, Allergy.

Neutrophil-Derived Cathelicidin Protects from Neointimal Hyperplasia

T. Gries, M. V. van Zandvoort, A. Zernecke, 2011, Science Translational Medicine.

Cathelicidin LL-37 in Severe Streptococcus pyogenes Soft Tissue Infections in Humans

A. Norrby-Teglund, D. Low, P. Sendi, 2008, Infection and Immunity.

The anti-microbial peptide LL-37/CRAMP levels are associated with acute heart failure and can attenuate cardiac dysfunction in multiple preclinical models of heart failure

J. Sluijter, Li-Long Pan, Jia Sun, 2020, Theranostics.

Li-Long Pan, Wenying Niu, X. Fang, 2020, British journal of pharmacology.

Pancreatic β-Cells Limit Autoimmune Diabetes via an Immunoregulatory Antimicrobial Peptide Expressed under the Influence of the Gut Microbiota.

P. van Endert, L. Saveanu, Jia Sun, 2015, Immunity.

The cathelicidins LL-37 and rCRAMP are associated with pathogenic events of arthritis in humans and rats

L. Bäckdahl, R. Holmdahl, A. Catrina, 2012, Annals of the rheumatic diseases.

The antimicrobial peptide LL‐37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils – implications for asthma

J. Haeggström, B. Dahlén, B. Agerberth, 2013, Allergy.

Induction of the human cathelicidin LL‐37 as a novel treatment against bacterial infections

L. Lindbom, B. Agerberth, P. Bergman, 2012, Journal of leukocyte biology.

The role of the multifunctional peptide LL-37 in host defense.

B. Agerberth, Y. Kai-Larsen, 2008, Frontiers in bioscience : a journal and virtual library.

Pancreatic b-Cells Limit A utoimmune Diabetes via an Immunoregulatory Antimicrobial Peptide Expressed under the Influence of the Gut Microbiota Graphical

P. Endert, L. Saveanu, Jia Sun, 2022 .

Cathelicidin LL‐37 induces time‐resolved release of LTB4 and TXA2 by human macrophages and triggers eicosanoid generation in vivo

J. Haeggström, O. Soehnlein, P. Uhlén, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Prostaglandin E2 suppresses hCAP18/LL‐37 expression in human macrophages via EP2/EP4: implications for treatment of Mycobacterium tuberculosis infection

R. Rekha, S. Brighenti, B. Agerberth, 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

J. Sluijter, Saumya Das, Li-Long Pan, 2019, BMC Medicine.

Leukotriene B4 triggers release of the cathelicidin LL‐37 from human neutrophils: novel lipid‐peptide interactions in innate immune responses

A. Sabirsh, A. Wetterholm, B. Agerberth, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A novel cysteine-linked antibacterial surface coating significantly inhibits bacterial colonization of nasal silicone prongs in a phase one pre-clinical trial.

H. Lagercrantz, J. Odeberg, J. Frie, 2018, Materials science & engineering. C, Materials for biological applications.

Sheep neuropeptide Y

V. Mutt, H. Jörnvall, R. Sillard, 1989, FEBS letters.

CD46 in Meningococcal Disease

T. Hökfelt, R. Cattaneo, B. Albiger, 2003, Science.

Phylogeny, processing and expression of the rat Cathelicidin rCRAMP: a model for innate antimicrobial peptides

M. Tollin, G. H. Gudmundsson, B. Agerberth, 2003, Cellular and Molecular Life Sciences CMLS.

Human-Like Immune Responses in CD46 Transgenic Mice1

T. Hökfelt, B. Agerberth, P. Bergman, 2005, The Journal of Immunology.

Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study

L. Ekström, J. Lindh, J. Andersson, 2012, BMJ Open.

The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis.

I. Lundberg, H. Alexanderson, M. Dastmalchi, 2017, Journal of autoimmunity.

Studies on citrullinated LL-37: detection in human airways, antibacterial effects and biophysical properties

Á. Végvári, A. Lindén, A. Gräslund, 2020, Scientific Reports.

Treatment with phenylbutyrate in a pre-clinical trial reduces diarrhea due to enteropathogenic Escherichia coli: link to cathelicidin induction.

A. Cravioto, A. Navarro, K. Talukder, 2013, Microbes and infection.

The host defense peptide LL‐37 is detected in human parotid and submandibular/sublingual saliva and expressed in glandular neutrophils

D. Ericson, D. Nebel, B. Agerberth, 2018, European journal of oral sciences.

Glucocorticoid dexamethasone down-regulates basal and vitamin D3 induced cathelicidin expression in human monocytes and bronchial epithelial cell line.

O. Sigurjonsson, G. H. Gudmundsson, B. Agerberth, 2016, Immunobiology.

Vitamin D3 and phenylbutyrate promote development of a human dendritic cell subset displaying enhanced antimicrobial properties

E. Kenne, L. Lindbom, B. Agerberth, 2014, Journal of leukocyte biology.

Assays for Identifying Inducers of the Antimicrobial Peptide LL-37.

G. H. Gudmundsson, B. Agerberth, P. Bergman, 2017, Methods in molecular biology.

Boosting innate immunity: Development and validation of a cell-based screening assay to identify LL-37 inducers

R. Strömberg, G. H. Gudmundsson, B. Agerberth, 2014, Innate immunity.

L-isoleucine-supplemented Oral Rehydration Solution in the Treatment of Acute Diarrhoea in Children: A Randomized Controlled Trial

R. Meier, M. Zasloff, F. Qadri, 2011, Journal of health, population, and nutrition.

Expression and Activity of β-Defensins and LL-37 in the Developing Human Lung1

P. McCray, G. H. Gudmundsson, B. Agerberth, 2005, The Journal of Immunology.

Expression and Activity of -Defensins and LL-37 in the Developing Human Lung

P. McCray, G. H. Gudmundsson, B. Agerberth, 2005 .

LL-37 in the Developing Human Lung-Defensins and β Expression and Activity of Gudmundsson and

P. McCray, G. H. Gudmundsson, B. Agerberth, 2005 .

The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa

H. Brismar, S. Lindow, A. Ulfgren, 2002, The British journal of dermatology.

The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations.

H. Jörnvall, R. Kiessling, L. Lindbom, 2000, Blood.

Malassezia sympodialis differently affects the expression of LL‐37 in dendritic cells from atopic eczema patients and healthy individuals

S. Gabrielsson, A. Scheynius, G. H. Gudmundsson, 2006, Allergy.

PR-39, a proline-rich peptide antibiotic from pig, and FALL-39, a tentative human counterpart.

J. Odeberg, H. G. Boman, G. H. Gudmundsson, 1996, Veterinary immunology and immunopathology.

Ciprofloxacin Affects Host Cells by Suppressing Expression of the Endogenous Antimicrobial Peptides Cathelicidins and Beta-Defensin-3 in Colon Epithelia

A. Mamun, R. Raqib, G. H. Gudmundsson, 2014, Antibiotics.

Citrullination Alters the Antibacterial and Anti-Inflammatory Functions of the Host Defense Peptide Canine Cathelicidin K9CATH In Vitro

J. Johansson, Á. Végvári, A. Rising, 2021, The Journal of Immunology.

Characterization of Biofilm Formation and the Role of BCR1 in Clinical Isolates of Candida parapsilosis

U. Römling, H. Lünsdorf, J. Morschhäuser, 2013, Eukaryotic Cell.

The Novel Inducer of Innate Immunity HO53 Stimulates Autophagy in Human Airway Epithelial Cells

S. Sigurdsson, M. H. Ogmundsdottir, E. Eskelinen, 2022, Journal of Innate Immunity.

Gut microbiota‐CRAMP axis shapes intestinal barrier function and immune responses in dietary gluten‐induced enteropathy

Li-Long Pan, Jia Sun, Y. Fu, 2021, EMBO molecular medicine.

Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity

R. Rekha, S. Brighenti, B. Agerberth, 2021, The Journal of infectious diseases.

Expression and activity of beta-defensins and LL-37 in the developing human lung.

P. McCray, G. H. Gudmundsson, B. Agerberth, 2005, Journal of immunology.

Cathelicidins positively regulate pancreatic β‐cell functions

J. Haeggström, Jia Sun, J. Diana, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Phenylbutyrate Counteracts Shigella Mediated Downregulation of Cathelicidin in Rabbit Lung and Intestinal Epithelia: A Potential Therapeutic Strategy

J. Andersson, R. Raqib, R. Rekha, 2011, PloS one.

Structure and activity of cathelicidin antibacterial proteins.

J. Johansson, Y. Wang, B. Agerberth, 1998, Journal of Protein Chemistry.

Label-Free Quantitative Mass Spectrometry Reveals Novel Pathways Involved in LL-37 Expression

G. H. Gudmundsson, B. Agerberth, P. Bergman, 2013, Journal of Innate Immunity.

Low Methoxyl Pectin Protects Against Autoimmune Diabetes and Associated Caecal Dysfunction.

Wei Chen, Hao Zhang, J. Lakey, 2019, Molecular nutrition & food research.

Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release.

B. Persson, V. Mutt, H. Jörnvall, 1988, European journal of biochemistry.

Isolation and characterization of a 60-residue intestinal peptide structurally related to the pancreatic secretory type of trypsin inhibitor: influence on insulin secretion.

V. Mutt, H. Jörnvall, S. Efendić, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Transgenic Mice Human-Like Immune Responses in CD46

T. Hökfelt, B. Agerberth, L. Johansson, 2022 .

Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial

R. Raqib, R. Rekha, S. Brighenti, 2015, PloS one.

PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells.

M. Tollin, G. H. Gudmundsson, B. Agerberth, 2008, Molecular immunology.

Treatment with Entinostat Heals Experimental Cholera by Affecting Physical and Chemical Barrier Functions of Intestinal Epithelia

R. Raqib, G. H. Gudmundsson, B. Agerberth, 2017, Antimicrobial Agents and Chemotherapy.

Cathelicidin Contributes to the Restriction of Leishmania in Human Host Macrophages

R. König, N. Reiling, G. van Zandbergen, 2019, Front. Immunol..

Biochemical and antibacterial analysis of human wound and blister fluid.

H. Jörnvall, T. Bergman, H. G. Boman, 1996, European journal of biochemistry.

Antimicrobial peptide LL‐37 promotes bacterial phagocytosis by human macrophages

J. Haeggström, L. Lindbom, B. Agerberth, 2014, Journal of leukocyte biology.

Antimicrobial peptides important in innate immunity

G. H. Gudmundsson, B. Agerberth, A. Cederlund, 2011, The FEBS journal.

Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity.

Y. Shai, J. C. Lerman, Z. Oren, 1999, The Biochemical journal.

Host antimicrobial defence peptides in human disease.

G. H. Gudmundsson, B. Agerberth, 2006, Current topics in microbiology and immunology.

Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator

B. Christensson, H. Wigzell, G. H. Gudmundsson, 2001, Nature Medicine.

Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37*

K. Berndt, M. Rottenberg, G. H. Gudmundsson, 1998, The Journal of Biological Chemistry.

The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory Disorders*

H. Wigzell, M. Ståhle-Bäckdahl, G. Ahangari, 1997, The Journal of Biological Chemistry.

Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides.

V. Mutt, H. Jörnvall, T. Bergman, 1991, European journal of biochemistry.

Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients.

H. Jörnvall, E. Castaños-Vélez, J. Grunewald, 1999, American journal of respiratory and critical care medicine.

Secondary structure and membrane interaction of PR-39, a Pro+Arg-rich antibacterial peptide.

J. Johansson, E. Goormaghtigh, J. Ruysschaert, 1994, European journal of biochemistry.

Direct analysis of peptides and amino acids from capillary electrophoresis

H. Jörnvall, T. Bergman, B. Agerberth, 1991, FEBS letters.

Cathelicidin LL-37 Induces Angiogenesis via PGE2–EP3 Signaling in Endothelial Cells, In Vivo Inhibition by Aspirin

J. Haeggström, L. Lindbom, B. Agerberth, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Involvement of the Antimicrobial Peptide LL-37 in Human Atherosclerosis

K. Mandal, Qingbo Xu, M. Rottenberg, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Antimicrobial Peptide LL‐37 Internalized by Immature Human Dendritic Cells Alters their Phenotype

A. Scheynius, G. H. Gudmundsson, B. Agerberth, 2006, Scandinavian journal of immunology.

Potent Inducers of Endogenous Antimicrobial Peptides for Host Directed Therapy of Infections

R. Strömberg, R. Raqib, G. H. Gudmundsson, 2016, Scientific Reports.

Phenylbutyrate Induces Antimicrobial Peptide Expression

J. Steinmann, S. Halldorsson, G. H. Gudmundsson, 2009, Antimicrobial Agents and Chemotherapy.

Host Directed Therapy Against Infection by Boosting Innate Immunity

R. Raqib, R. Rekha, G. H. Gudmundsson, 2020, Frontiers in Immunology.

A review of the innate immune defence of the human foetus and newborn, with the emphasis on antimicrobial peptides

G. H. Gudmundsson, B. Agerberth, Y. Kai-Larsen, 2014, Acta paediatrica.

Chapter 6 Viktor Mutt: A Giant in the Field of Bioactive Peptides

H. Jörnvall, M. Zasloff, B. Agerberth, 2008 .

Pancreatic secretory trypsin inhibitor (PSTI) isolated from pig intestine Influence on insulin and somatostatin release

C. Östenson, H. Jörnvall, S. Efendić, 1991, FEBS letters.

Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages.

O. Soehnlein, E. Kenne, L. Lindbom, 2008, The Journal of clinical investigation.

Innate lymphoid cell type 3–derived interleukin-22 boosts lipocalin-2 production in intestinal epithelial cells via synergy between STAT3 and NF-κB

U. Lindforss, J. Mjösberg, B. Agerberth, 2019, The Journal of Biological Chemistry.

Phenylbutyrate induces cathelicidin expression via the vitamin D receptor: Linkage to inflammatory and growth factor cytokines pathways.

G. H. Gudmundsson, B. Agerberth, N. Kulkarni, 2015, Molecular immunology.

Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7-42), diazepam-binding inhibitor (32-86) and a novel factor, peptide 3910.

V. Mutt, H. Jörnvall, H. G. Boman, 1993, European journal of biochemistry.

Hsp90 binds CpG oligonucleotides directly: implications for Hsp90 as a missing link in CpG signaling and recognition

J. Shabanowitz, D. Hunt, C. Palmberg, 2003, Cellular and Molecular Life Sciences CMLS.

Decreased pulmonary levels of the anti-inflammatory Clara cell 16 kDa protein after induction of airway inflammation in asthmatics

H. Jörnvall, J. Grunewald, A. Eklund, 2000, Cellular and Molecular Life Sciences CMLS.

LL-37 is expressed in the inflamed synovium in patients with rheumatoid arthritis and downregulated by TNF inhibitors

M. Engström, A. Catrina, B. Agerberth, 2012 .

NK‐lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity.

V. Mutt, H. Jörnvall, T. Bergman, 1995, The EMBO journal.

Differential expression of enteric neuroimmune‐network in invasive and acute watery diarrhoea

F. Qadri, M. Mathan, J. Andersson, 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation

R. Raqib, R. Rekha, B. Agerberth, 2020, Antibiotics.

Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice

P. de Vos, Wei Chen, Hao Zhang, 2019, Front. Immunol..

University of Groningen Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice

P. Vos, Wei Chen, Hao Zhang, 2019 .

Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice

P. Vos, Wei Chen, Hao Zhang, 2019 .

Innate Effector Systems in Primary Human Macrophages Sensitize Multidrug-Resistant Klebsiella pneumoniae to Antibiotics

R. Rekha, G. H. Gudmundsson, B. Agerberth, 2020, Infection and Immunity.

Protecting effects of vasoactive intestinal polypeptide on lymphocytes against metal toxicity.

K. Nordlind, B. Agerberth, L. Bondesson, 1992, Immunopharmacology and immunotoxicology.

Molecular cloning of PEC-60 and expression of its mRNA and peptide in the gastrointestinal tract and immune system.

V. Mutt, P. Ernfors, M. Metsis, 1992, The Journal of biological chemistry.

The antimicrobial peptide LL-37 binds to the human plasma protein apolipoprotein A-I.

J. Johansson, H. Jörnvall, W. Griffiths, 2004, Rapid communications in mass spectrometry : RCM.

Differential Host Immune Responses to Epidemic and Endemic Strains of Shigella dysenteriae Type 1

K. Talukder, R. Raqib, R. Rekha, 2011, Journal of health, population, and nutrition.

populations-defensins are expressed by specific lymphocyte and monocyte α The human antimicrobial and chemotactic peptides

H. Jörnvall, L. Lindbom, H. Wigzell, 2000 .

Novel aroylated phenylenediamine compounds enhance antimicrobial defense and maintain airway epithelial barrier integrity

R. Strömberg, Z. Parveen, G. H. Gudmundsson, 2019, Scientific Reports.

Daily adjunctive therapy with vitamin D3 and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: a randomized controlled trial in Ethiopia

A. Worku, A. Aseffa, J. Andersson, 2018, Journal of internal medicine.

Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages

R. Raqib, R. Rekha, S. Brighenti, 2015, Autophagy.

Antimicrobial peptides in the first line defence of human colon mucosa

H. Jörnvall, M. Tollin, G. H. Gudmundsson, 2003, Peptides.

Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system.

G. H. Gudmundsson, B. Agerberth, 1999, Journal of immunological methods.

Identification of a potent antibacterial factor isolated from bronchoalveolar lavage fluid: guanidine, N-[3-[(aminoiminomethyl)amino]propyl]-N-dodecyl-, a potential source of error in the analysis of antibacterial agents.

J. Grunewald, W. Griffiths, G. H. Gudmundsson, 2003, Rapid communications in mass spectrometry : RCM.

Proteome Analysis of Vernix Caseosa

H. Jörnvall, M. Tollin, B. Agerberth, 2006, Pediatric Research.

Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D3 as host directed therapy

R. Raqib, R. Rekha, P. Hiemstra, 2018, BMC Infectious Diseases.

A trypsin inhibitor-like peptide PEC-60 reduces the affinity of dopamine D2 agonist binding sites in rat neostriatal membranes.

V. Mutt, S. Ferré, B. Agerberth, 1991, European journal of pharmacology.

PEC-60, a novel porcine 60-residue intestinal peptide, reduces dopamine utilization in discrete parts of the neostriatum of the male rat following an intracerebroventricular injection.

K. Fuxe, L. Agnati, V. Mutt, 1991, Acta physiologica Scandinavica.

Generalized presence of a PEC-60-like peptide in catecholamine neurones.

K. Fuxe, W. Staines, L. Agnati, 1994, Neuroreport.

V. Mutt, C. Östenson, H. Jörnvall, 1988, European journal of biochemistry.